Rena Dearment
Endocrinology, Diabetes & Metabolism · Camp Hill, PANPI 1235197971
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $79,746 of the $104,116 with a category attached, or 76.6%. It is spread thinly across 27 manufacturers, the largest accounting for just 23.3%. Among endocrinology, diabetes & metabolism clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 495 payments — averaging $210.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$24K
- Abbott$20K
- Boehringer Ingelheim$18K
- Lilly USA, LLC$17K
- Amarin Pharma, Inc.$17K
- Johnson & Johnson$5K
- plus $3K from 21 others
What the payments were for
- Consulting fees$5,6755%
- Speaking & faculty fees$79,74677%
- Travel & lodging$11,38511%
- Food & beverage$7,2867%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $24,240 |
| Abbott | 43 | $19,996 |
| Boehringer Ingelheim | 71 | $18,052 |
| Lilly USA, LLC | 74 | $17,390 |
| Amarin Pharma, Inc. | 44 | $16,831 |
| Johnson & Johnson | 33 | $5,074 |
| Sanofi-aventis U.S. LLC | 46 | $650 |
| Amgen | 25 | $389 |
| AstraZeneca | 18 | $323 |
| Merck | 20 | $276 |
| AbbVie | 10 | $164 |
| Corcept Therapeutics | 11 | $149 |
| Mannkind Corporation | 6 | $92 |
| Kowa Pharmaceuticals America, Inc. | 6 | $78 |
| Tandem Diabetes Care, Inc. | 6 | $75 |
| Dexcom, Inc. | 5 | $66 |
| Shire North American Group Inc | 3 | $51 |
| Amneal Pharmaceuticals LLC | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| IBSA Pharma Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| Senseonics, Incorporated | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Lifescan, Inc. | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$33,415
- FreeStyle Libre Pro$19,056
- Vascepa$15,968
- Ozempic$9,572
- Tresiba$5,520
- INVOKANA$4,680
- Xultophy 100/3.6$4,185
- RYBELSUS$3,232
How this compares
$104,116 in reported general payments places this provider in the 90th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.
See all endocrinology, diabetes & metabolism providers in Pennsylvania →
Other endocrinology, diabetes & metabolism in Camp Hill
- Serge JabbourPhiladelphia$1.2M
- Vijay BahlPittsburgh$998K
- Geraldo SaavedraWhitehall$698K
- Jane MayrinPhiladelphia$628K
- Stephan KowalykGreensburg$591K
- Matthew KaneWest Chester$577K
- Intekhab AhmedPhiladelphia$528K
- Swarna VarmaPittsburgh$520K
- James DickeHanover$425K
- Mitchell LazarPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.